pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,831
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Phase 3
etentamig
etentamig
Refractory Multiple Myeloma
$ABBV
AbbVie Inc.
Marketed
ethacrynate sodium
Ethacrynate Sodium
Hepatic Edema
SteriMax Inc
Marketed
ethacrynic acid
Ethacrynic Acid
Lymphedema
Agnitio Inc
Phase 2
← prev
page 46 of 62
next →
Pain
89
Neurology
1
etigilimab
etigilimab
Adenocarcinoma Of The Gastroesophageal Junction
$MREO
Mereo BioPharma Group plc
Phase 2
etivelcabtagene erigedleucel
etivelcabtagene erigedleucel
Follicular Lymphoma
Cellectis SA
Phase 2
evalstotug
evalstotug [INN]
Melanoma
$BCAB
BioAtla, Inc.
Phase 2
evarucabgene autoleucel
evarucabgene autoleucel
Refractory Multiple Myeloma
Nexcella Inc
Phase 3
evorpacept
evorpacept
Adenocarcinoma Of The Gastroesophageal Junction
$ALXO
ALX ONCOLOGY HOLDINGS INC
Phase 1
exarafenib
exarafenib [INN]
Melanoma
Laboratoires Pierre Fabre SA
Phase 2
ezurpimtrostat
ezurpimtrostat [INN]
Bile Duct Cancer (Cholangiocarcinoma)
Genfit SA
Phase 1
faldoritinib
faldoritinib
Refractory Acute Myeloid Leukemia
$BMEA
Biomea Fusion, Inc.
Marketed
famotidine
Pepcid (famotidine)
Acid Indigestion (Heartburn/Pyrosis)
$KVUE
Kenvue Inc.
Phase 1
faridoxorubicin
faridoxorubicin [INN]
Dedifferentiated Liposarcoma
Avacta Life Sciences Ltd
Phase 2
farletuzumab ecteribulin
farletuzumab ecteribulin
Triple-Negative Breast Cancer (TNBC)
Eisai Co Ltd
Phase 1
fb-PMT
Recurrent Glioblastoma Multiforme (GBM)
NanoPharmaceuticals LLC
Phase 2
fenretinide
fenretinide
Dengue Fever
$ILPLF
Island Pharmaceuticals Ltd
Phase 2
fexapotide triflutate
fexapotide triflutate
Prostate Cancer
$NYMXF
NYMOX PHARMACEUTICAL CORP
Phase 3
fianlimab
fianlimab
Metastatic Melanoma
$REGN
REGENERON PHARMACEUTICALS, INC.
Phase 3
ficerafusp alfa
ficerafusp alfa
Recurrent Head And Neck Squamous Cell Carcinoma
$BCAX
Bicara Therapeutics Inc.
Phase 3
ficlatuzumab
ficlatuzumab
Recurrent Head And Neck Squamous Cell Carcinoma
AVEO Pharmaceuticals Inc
Marketed
fingolimod ODT
Tascenso ODT (fingolimod [INN])
Multiple Sclerosis
Cycle Pharmaceuticals Ltd
Phase 1
flezurafenib
flezurafenib
Hematological Tumor
$JAZZ
Jazz Pharmaceuticals plc
Phase 2
flixebrutinib
flixebrutinib
Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
Telios Pharma Inc
Marketed
floxuridine
Floxuridine
Adenocarcinoma Of The Gastroesophageal Junction
Fresenius Kabi USA LLC
Phase 2
flucytosine ER + vocimagene amiretrorepvec
flucytosine + vocimagene amiretrorepvec
Glioblastoma Multiforme (GBM)
Denovo Biopharma LLC
Marketed
fludarabine phosphate
Fludarabine Phosphate
B-Cell Chronic Lymphocytic Leukemia
Areva Pharmaceuticals Inc
Marketed
flutamide
Flutamide
Metastatic Prostate Cancer
Par Pharmaceutical Inc
Preclinical
fosbretabulin tromethamine
fosbretabulin tromethamine
Metastatic Melanoma
$OTLC
Oncotelic Therapeutics, Inc.
Phase 2
foscenvivint
foscenvivint [INN]
Colorectal Cancer
Eisai Co Ltd
Phase 2
fosdesdenosine sipalabenamide
fosdesdenosine sipalabenamide [INN]
Metastatic Melanoma
$NCNA
NuCana plc
